T. Rowe Price Investment Management’s Herc Holdings HRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-53,438
Closed -$7.93M 780
2025
Q4
$7.93M Sell
53,438
-11,732
-18% -$1.61M 0.01% 566
2025
Q3
$7.6M Sell
65,170
-38,715
-37% -$4.99M ﹤0.01% 567
2025
Q2
$13.7M Sell
103,885
-225,113
-68% -$27.3M 0.01% 534
2025
Q1
$44.2M Sell
328,998
-190,095
-37% -$32.4M 0.03% 421
2024
Q4
$98.3M Sell
519,093
-117,232
-18% -$23.6M 0.06% 296
2024
Q3
$101M Sell
636,325
-1,465
-0.2% -$208K 0.06% 293
2024
Q2
$85M Sell
637,790
-47,383
-7% -$7M 0.05% 308
2024
Q1
$115M Buy
685,173
+28,988
+4% +$4.41M 0.07% 266
2023
Q4
$97.7M Buy
656,185
+45,895
+8% +$5.62M 0.06% 277
2023
Q3
$72.6M Buy
610,290
+91,322
+18% +$11.9M 0.05% 307
2023
Q2
$71M Buy
518,968
+107,076
+26% +$11.9M 0.05% 318
2023
Q1
$46.9M Buy
411,892
+31,751
+8% +$4.38M 0.03% 376
2022
Q4
$50M Buy
380,141
+83,876
+28% +$10.3M 0.04% 353
2022
Q3
$30.8M Buy
+296,265
New +$32.9M 0.02% 401

Other funds holding HRI

T. Rowe Price Investment Management's HRI Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Herc Holdings (HRI) in Q1 2026, closing a stake of 53,438 shares — an estimated $7.93M sold.

T. Rowe Price Investment Management first reported a position in HRI in Q3 2022 and held it in 14 quarters. The position peaked at $115M in Q1 2024. 301 funds tracked by Wall St. Rank hold HRI as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining Herc Holdings position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 53,438 Herc Holdings shares in Q1 2026, an estimated $7.93M.
  • T. Rowe Price Investment Management first reported a position in Herc Holdings in Q3 2022 and held it in 14 quarters.
  • T. Rowe Price Investment Management's Herc Holdings position peaked at $115M in Q1 2024.
  • 301 funds tracked by Wall St. Rank held Herc Holdings as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.